ADA and severe combined immunodeficiency: This is highly successful, as corroborated by recent regulatory approvals for adenosine deaminase (ADA)‐deficient severe combined immunodeficiency (SCID), and can provide a life-long cure for patients that cannot be treated with bone marrow transplantation [84,85].